Microglia In Parkinson Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
In Parkinson's disease, microglial activation is a hallmark pathological feature. The substantia nigra pars compacta shows dense microglial infiltration surrounding dopaminergic neurons, creating a chronic neuroinflammatory environment.
- Resting state: Surveying brain parenchyma
- Marker expression: P2ry12, TMEM119, CX3CR1
- Function: Immune surveillance
- Triggered by: Neuronal damage signals
- Marker changes: Downregulation of P2ry12, upregulation of TREM2
- Function: Phagocytic clearance
- Pro-inflammatory:持续释放促炎因子
- ROS production: NADPH oxidase activation
- Neurotoxic: Contributing to neuronal death
- α-Synuclein: Activates microglia via TLRs
- ATP: P2X7 receptor activation
- Heat shock proteins: Extracellular release
- Nuclear proteins: HMGB1 release
- TLR2/TLR4: Recognize α-synuclein
- NF-κB activation: Pro-inflammatory gene expression
- Cytokine production: TNF-α, IL-1β, IL-6
- TNF-α: Potent pro-inflammatory cytokine
- IL-1β: IL-1 family cytokine
- IL-6: Multi-functional cytokine
- ROS/RNS: Reactive nitrogen species
- Dopaminergic neuron death: Direct toxicity
- Oxidative stress: Increased ROS production
- Excitotoxicity: Glutamate release
- Synaptic pruning: Complement-mediated elimination
- Minocycline: Microglial inhibitor (clinical trials)
- Natalizumab: Anti-integrin therapy
- TGF-β: Anti-inflammatory cytokine
- COX-2 inhibitors: Reduce prostaglandin production
- Antioxidants: N-acetylcysteine, glutathione
- Microglial depletion: CSF1R antagonists
- PET imaging shows increased TSPO binding in PD SNc
- Post-mortem studies reveal 3-5x microglial density increase
- Animal models demonstrate neuroprotection with microglial inhibition
- Genetic variants in microglia-related genes affect PD risk
The study of Microglia In Parkinson Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- McGeer PL, et al. (1988). Reactive microglia are positive for HLA-DR. Neurology.
- Hoeijmakers L, et al. (2017). Microglia in neurodegeneration. Nat Rev Neurol.
- Sugama S, et al. (2021). Microglial activation in Parkinson's disease. J Neural Transm.